This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Bahnson, E. E. Articles by Bahnson, R. R. Social Bookmarking                         What's this?

PET/CT imaging of clear cell renal cell carcinoma with 124I labeled chimeric antibody

Department of Radiology, The Ohio State University, Columbus, OH 43210, USA

Douglas A. Murrey, Jr, MD

Department of Radiology, The Ohio State University, Columbus, OH 43210, USA

Cathy M. Mojzisik, RN, MS

Department of Radiology, The Ohio State University, Columbus, OH 43210, USA

Nathan C. Hall, MD, PhD

Department of Radiology, The Ohio State University, Columbus, OH 43210, USA

Humberto J. Martinez-Suarez, MD

Department of Urology, The Ohio State University, Columbus, OH 43210, USA

Michael V. Knopp, MD, PhD

Department of Radiology, The Ohio State University, Columbus, OH 43210, USA

Edward W. Martin, Jr, MD

Department of Surgical Oncology, The Ohio State University, Columbus, OH 43210, USA

Stephen P. Povoski, MD

Department of Surgical Oncology, The Ohio State University, Columbus, OH 43210, USA

Robert R. Bahnson, MD

Department of Urology, The Ohio State University, Columbus, OH 43210, USA, robert.bahnson{at}osumc

Clear cell renal cell carcinoma (ccRCC) presents problems for urologists in diagnosis, treatment selection, intraoperative surgical margin analysis, and long term monitoring. In this paper we describe the development of a radiolabeled antibody specific to ccRCC (124I-cG250) and its potential to help urologists manage each of these problems. We believe 124I-cG250, in conjunction with perioperative Positron emission tomography/ computed tomography imaging and intraoperative handheld gamma probe use, has the potential to diagnose ccRCC, aid in determining a proper course of treatment (operative or otherwise), confirm complete resection of malignant tissue in real time, and monitor patients post-operatively.

Key Words: advanced kidney cancer • kidney cancer basic research • kidney cancer evaluation/staging • kidney cancer localized • kidney cancer

References

• Brouwers, A.H., Dorr, U., Lang, O., Boerman, O.C., Oyen, W.J., Steffens, M.G. et al. (2002) 131 I-Cg250 Monoclonal Antibody Immunoscintigraphy Versus [18 F]Fdg-Pet Imaging in Patients with Metastatic Renal Cell Carcinoma: A Comparative Study. Nucl Med Commun 23: 229-236.[CrossRef][Medline] [Order article via Infotrieve]
• Cohn, D.E., Hall, N.C., Povoski, S.P., Seamon, L.G., Farrar, W.B. and Martin Jr, E.W. (2008) Novel Perioperative Imaging with 18f-Fdg Pet/Ct and Intraoperative 18f-Fdg Detection Using a Handheld Gamma Probe in Recurrent Ovarian Cancer. Gynecol Oncol 110: 152-157.[CrossRef][Medline] [Order article via Infotrieve]
• Divgi, C.R., Pandit-Taskar, N., Jungbluth, A.A., Reuter, V.E., Gonen, M., Ruan, S. et al. (2007) Preoperative Characterisation of Clear-Cell Renal Carcinoma Using Iodine-124-Labelled Antibody Chimeric G250 (124i-Cg250) and Pet in Patients with Renal Masses: A Phase I Trial. Lancet Oncol 8: 304-310.[CrossRef][Medline] [Order article via Infotrieve]
• Fergany, A.F., Hafez, K.S. and Novick, A.C. (2000) Long-Term Results of Nephron Sparing Surgery for Localized Renal Cell Carcinoma: 10-Year Followup. J Urol 163: 442-445.[CrossRef][Medline] [Order article via Infotrieve]
• Fergany, A.F., Saad, I.R., Woo, L. and Novick, A.C. (2006) Open Partial Nephrectomy for Tumor in a Solitary Kidney: Experience with 400 Cases. J Urol 175: 1630-1633; discussion 1633.[CrossRef]
• Hall, N.C., Povoski, S.P., Murrey, D.A., Knopp, M.V. and Martin, E.W. (2008) Bringing Advanced Medical Imaging into the Operative Arena Could Revolutionize the Surgical Care of Cancer Patients. Expert Rev Med Devices 5: 663-667.[CrossRef][Medline] [Order article via Infotrieve]
• Hall, N.C., Povoski, S.P., Murrey, D.A., Knopp, M.V. and Martin Jr, E.W. (2007) Combined Approach of Perioperative 18f-Fdg Pet/Ct Imaging and Intraoperative 18f-Fdg Handheld Gamma Probe Detection for Tumor Localization and Verification of Complete Tumor Resection in Breast Cancer. World J Surg Oncol 5: 143.[CrossRef][Medline] [Order article via Infotrieve]
• Huang, W.C., Elkin, E.B., Levey, A.S., Jang, T.L. and Russo, P. (2009) Partial Nephrectomy Versus Radical Nephrectomy in Patients with Small Renal Tumors-- Is There a Difference in Mortality and Cardiovascular Outcomes? J Urol 181: 55-61; discussion 61-52.
• Kang, D.E., White Jr, R.L., Zuger, J.H., Sasser, H.C. and Teigland, C.M. (2004) Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell Carcinoma. J Urol 171: 1806-1809.[CrossRef][Medline] [Order article via Infotrieve]
• Majhail, N.S., Urbain, J.L., Albani, J.M., Kanvinde, M.H., Rice, T.W., Novick, A.C. et al. (2003) F-18 Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Distant Metastases from Renal Cell Carcinoma. J Clin Oncol 21: 3995-4000.[Abstract/Free Full Text]
• Miyakita, H., Tokunaga, M., Onda, H., Usui, Y., Kinoshita, H., Kawamura, N. et al. (2002) Significance of 18f-Fluorodeoxyglucose Positron Emission Tomography (Fdg-Pet) for Detection of Renal Cell Carcinoma and Immunohistochemical Glucose Transporter 1 (Glut-1) Expression in the Cancer. Int J Urol 9: 15-18.[CrossRef][Medline] [Order article via Infotrieve]
• Oosterwijk, E., Ruiter, D.J., Hoedemaeker, P.J., Pauwels, E.K., Jonas, U., Zwartendijk, J. et al. (1986a) Monoclonal Antibody G 250 Recognizes a Determinant Present in Renal-Cell Carcinoma and Absent from Normal Kidney. Int J Cancer 38: 489-494.[Medline] [Order article via Infotrieve]
• Oosterwijk, E., Ruiter, D.J., Wakka, J.C., Huiskens-Van Der Meij, J.W., Jonas, U., Fleuren, G.J. et al. (1986b) Immunohistochemical Analysis of Monoclonal Antibodies to Renal Antigens. Application in the Diagnosis of Renal Cell Carcinoma. Am J Pathol 123: 301-309.[Abstract]
• Povoski, S.P., Hall, N.C., Martin Jr, E.W. and Walker, M.J. (2008) Multimodality Approach of Perioperative 18f-Fdg Pet/Ct Imaging, Intraoperative 18f-Fdg Handheld Gamma Probe Detection, and Intraoperative Ultrasound for Tumor Localization and Verification of Resection of All Sites of Hypermetabolic Activity in a Case of Occult Recurrent Metastatic Melanoma. World J Surg Oncol 6: 1.[CrossRef][Medline] [Order article via Infotrieve]
• Povoski, S.P., Neff, R.L., Mojzisik, C.M., O'malley, D.M., Hinkle, G.H., Hall, N.C. et al. (2009) A Comprehensive Overview of Radioguided Surgery Using Gamma Detection Probe Technology. World J Surg Oncol 7: 11.[CrossRef][Medline] [Order article via Infotrieve]
• Sarikaya, I., Povoski, S.P., Al-Saif, O.H., Kocak, E., Bloomston, M., Marsh, S. et al. (2007) Combined Use of Preoperative 18f Fdg-Pet Imaging and Intraoperative Gamma Probe Detection for Accurate Assessment of Tumor Recurrence in Patients with Colorectal Cancer. World J Surg Oncol 5: 80.[CrossRef][Medline] [Order article via Infotrieve]
• Steffens, M.G., Boerman, O.C., Oosterwijk-Wakka, J.C., Oosterhof, G.O., Witjes, J.A., Koenders, E.B. et al. (1997) Targeting of Renal Cell Carcinoma with Iodine-131-Labeled Chimeric Monoclonal Antibody G250. J Clin Oncol 15: 1529-1537.[Abstract]

This version was published on June 1, 2009

Therapeutic Advances in Urology, Vol. 1, No. 2, 67-70 (2009)
DOI: 10.1177/1756287209105264


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Bahnson, E. E. Articles by Bahnson, R. R. Social Bookmarking                         What's this?